The company
Lifecore Biomedical, Inc.
LFCR · Nasdaq
LFCR stood above a rising 150-day average in 14 of the last 52 weekly readings, and has been out of that trend for the last 37 weeks. It is 30.1% above that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Above a falling average
- Weeks in an uptrend
- out for 37
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 96 (-2)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 14 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| WYNNEFIELD CAPITAL INCunchanged · filed 14 Aug 2026 | 4,703,216$24.7M | 00.0% |
| Legion Partners Asset Management, LLCunchanged · filed 14 Aug 2026 | 4,461,823$23.4M | 00.0% |
| Greenhaven Road Investment Management, L.P.reduced · filed 14 Aug 2026 | 3,190,769$16.8M | -346,804−9.8% |
| 325 CAPITAL LLCadded · filed 14 Aug 2026 | 2,895,881$15.2M | +733,415+33.9% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 2,013,093$10.6M | +135,788+7.2% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 1,288,621$6.8M | -1,515−0.1% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 855,500$4.5M | +40,393+5.0% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 769,360$4.0M | +4,626+0.6% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 668,031$3.5M | +26,025+4.1% |
| Quinn Opportunity Partners LLCunchanged · filed 14 Aug 2026 | 453,495$2.4M | 00.0% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.